No Data
Zhixiang Jintai: Third Quarter Report 2024
Third Quarter Report 2024
Private Equity Firms Who Have a Significant Stake Must Be Disappointed Along With Institutions After Chongqing Genrix Biopharmaceutical Co., Ltd.'s (SHSE:688443) Market Cap Dropped by CN¥1.3b
Zhixiang Jintai (688443.SH): intends to invest 20 million yuan to 40 million yuan in repurchasing shares.
Gelonghui October 15th | Zhixiang Jintai (688443.SH) announced that the company's share repurchase this time is intended to be used for employee stock ownership plans or stock-based incentives at a suitable future time. The amount of share repurchase shall not be less than RMB 20 million (including the principal amount), and shall not exceed RMB 40 million (including the principal amount). The repurchase price of shares shall not exceed RMB 39.83 per share.
Zhixiang Jintai (688443.SH): 25 million restricted shares will be unlocked on September 27th.
On September 19th, Gelunhui (688443.SH) announced that the total number of stocks listed and traded by the company this time is 25 million shares. The date of listing and trading of the stocks is September 27th, 2024.
Chongqing Genrix Biopharmaceutical Chair Proposes Up to 40-Million-Yuan Share Buyback
No Data
No Data